Bio Techne reported $350.04M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Agilent USD 1.76B 49M Jun/2026
Becton, Dickinson and Co. USD 725M 17M Sep/2026
Bio Techne USD 350.04M 85.32M Sep/2026
Bio-Rad Laboratories USD 465.3M 51.7M Sep/2026
Bruker USD 184.9M 51.5M Jun/2026
Charles River Laboratories USD 200.38M 8.36M Sep/2026
Danaher USD 5.68B 1.33B Sep/2026
Illumina USD 1.29B 249M Sep/2026
IQVIA Holdings USD 2.25B 340M Sep/2026
Merck EUR 1.96B 788M Jun/2026
Mettler Toledo International USD 52.24M 854K Sep/2026
OraSure Technologies USD 160.58M 16.38M Jun/2026
Pacific Biosciences Of California USD 55.91M 5.1M Sep/2026
Repligen USD 726.96M 120.18M Sep/2026
Revvity USD 592.8M 430.14M Sep/2026
Standard Biotools USD 267.49M 2.54M Sep/2026
Thermo Fisher Scientific USD 5.46B 1.4B Sep/2026
Waters USD 593M 54M Sep/2026